Selective antagonism of the ET(A) receptor reduces neointimal hyperplasia after balloon-induced vascular injury in pigs

Journal of Cardiovascular Pharmacology

Volumn 30, Issue 1, 1997, Pages 33-41

  Burke, Sandra E ^a   Lubbers, Nathan L ^a   Gagne, Gerard D ^a   Wessale, Jerry L ^a   Dayton, Brian D ^a   Wegner, Craig D ^a   Opgenorth, Terry J ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

Angioplasty; Collagen; Endothelin; Neointima; Restenosis

Indexed keywords

ANGIOTENSIN I; ATRASENTAN; CAPTOPRIL; COLLAGEN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD VESSEL INJURY; CAROTID ARTERY; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; ILIAC ARTERY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RESTENOSIS; SWINE;

ANGIOPLASTY, BALLOON; ANGIOTENSIN I; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; CAPTOPRIL; CAROTID ARTERY INJURIES; CAROTID ARTERY, COMMON; COLLAGEN; ENDOTHELIN-1; HYPERPLASIA; ILIAC ARTERY; MALE; MUSCLE, SMOOTH, VASCULAR; PYRROLIDINES; RECEPTOR, ENDOTHELIN A; RECEPTORS, ENDOTHELIN; SWINE; SWINE, MINIATURE; TUNICA INTIMA;

EID: 0030722183     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199707000-00006     Document Type: Article

References (26)

1. Opgenorth TJ. Endothelin receptor antagonism. In: August JT, Anders MW, Murad F, Coyle JT, eds. Advances in pharmacology. Vol 33. San Diego, CA: Academic Press, 1995:1-65.
2. Levin ER. Endothelins. N Engl J Med 1995;333:356-63.
3. Douglas SA, Ohlstein EH. Endothelin-1 promotes neointima formation after balloon angioplasty in the rat. J Cardiovasc Pharmacol 1993;22(suppl 8):S371-3.
4. Ohlstein EH, Douglas SA. Endothelin-1 modulates vascular smooth muscle structure and vasomotion: implications in cardiovascular pathology. Drug Dev Res 1993;29:108-28.
5. Bobik A, Grooms A, Millar JA, Mitchell A, Grinpukel S. Growth factor activity of endothelin on vascular smooth muscle. Am J Physiol 1990;258:C408-15.
6. Hirata Y, Takagi Y, Fukuda Y, Marumo F. Endothelin is a potent mitogen for rat vascular smooth muscle cells. Arteriosclerosis 1989; 78: 225-8.
7. Ohlstein EH, Arleth A, Bryan H, Elliott JD, Sung CP. The selective endothelin ETA receptor antagonist BQ 123 antagonizes endothelin-1-mediated mitogenesis. Eur J Pharmacol 1992;225:347-50.
8. Trachtenberg JD, Sun S, Choi ET, Callow AD, Ryan US. Effect of endothelin-1 infusion on the development of intimal hyperplasia after balloon catheter injury. J Cardiovasc Pharmacol 1993;22 (suppl 8):S355-9.
9. Wessale J, Adler A, Novosad E, Burke S, Dayton B, Opgenorth T. Endothelin antagonism reduces neointima formed following balloon injury in rabbit [Abstract]. Fourth International Conference on Endothelin. London, UK, April 23-26, 1995:153.
10. Jackson CL. Animal models of restenosis. Trends Cardiovasc Med 1994;4:122-30.
11. Faxon DP. Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril: the Multicenter American Research trial with cilazapril after angioplasty to prevent transluminal coronary obstruction and restenosis (MARCATOR) study group. J Am Coll Cardiol 1995; 25:362-9.
12. Schwartz RS, Murphy JG, Edwards WD, Camrud AR, Vliestra RE, Holmes DR. Restenosis after balloon angioplasty: a practical proliferative model in porcine coronary arteries. Circulation 1990;82: 2190-200.
13. A-selective receptor antagonist. J Pharmacol Exp Ther 1996; 276: 473-81.
14. Huber KC, Schwartz RS, Edwards WD, et al. Effects of angiotensin converting enzyme inhibition on neointimal proliferation in a porcine coronary injury model. Am Heart J 1993;125:695-701.
15. Lam JYT, Lacoste L, Bourassa MG. Cilazapril and early atherosclerotic changes after balloon injury of porcine carotid arteries. Circulation 1992;85:1542-7.
16. Löffler B-M, Breu V, Clozel M. Effect of different endothelin receptor antagonists and of the novel non-peptide antagonist Ro 46-2005 on endothelin levels in rat plasma. FEBS Lett 1993; 333: 108-10.
17. Teerlink JR, Carteaux J-P, Sprecher U, Löffler B-M, Clozel M, Clozel J-P. Role of endogenous endothelin in normal hemodynamic status of anesthetized dogs. Am J Physiol 1995;268:H432-40.
18. Steele PM, Chesebro JH, Stanson AW, et al. Balloon angioplasty: natural history of the pathophysiological response to injury in a pig model. Circ Res 1985;57:105-12.
19. Davies MG, Hagen P-O. Pathobiology of intimal hyperplasia. Br J Surg 1994;81:1254-69.
20. Ang AH, Tachas G, Campbell JH, Bateman JF, Campbell GR. Collagen synthesis by cultured rabbit aortic smooth-muscle cells: alteration with phenotype. Biochem J 1990;265:461-9.
21. Nakamura T, Ebihara I, Fukui M, Tomino Y, Koide H. Effect of a specific endothelin receptor A antagonist on mRNA levels for extracellular matrix components and growth factors in diabetic glomeruli. Diabetes 1995;44:895-9.
22. B binding sites in human coronary vasculature. J Cardiovasc Pharmacol 1995;26(suppl 3):S351-4.
23. Rigel DF, Lappe RW. Differential responsiveness of conduit and resistance coronary arteries to endothelin A and B receptor stimulation in anesthetized dogs. J Cardiovasc Pharmacol 1995; 22(suppl 8):S243-7.
24. A receptors predominate in the human vasculature and mediate constriction. J Cardiovasc Pharmacol 1995;26(suppl 3):S265-7.
25. Powell JS, Clozel JP, Müller RKM, et al. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 1989;245:186-8.
26. Desmet W, Vrolix M, De Scheerder I, Van Lierde J, Willems JL, Piessens J. Angiotensin-converting enzyme inhibition with fosinopril sodium in the prevention of restenosis after coronary angioplasty. Circulation 1994:89;385-92.